Thoratec Corporation Medical Equipment Company Report

Summary

Thoratec Corporation Medical Equipment Company Report

Summary

This report is an essential source for data, analysis and strategic insight into this company. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

• Revenues for the markets and sub-sectors the company operates in by country and region.
• Detailed breakdowns of revenues and market share benchmarked against competitors.
• Profiles of the pipeline of products that the company is developing.
• Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
• Provides summary analysis of key revenue lines and strategy.
• Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
• Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

• A single source to fulfill all of your business and competitor intelligence needs
• Research your competitors' business structure, strategy and prospects.
• Counter your competitors' strengths and target their weaknesses.
• Identify your competitors' key revenue streams by market and geography.
• Identify & assess potential corporate and investment opportunities
• Support sales activities by understanding your customers' businesses better.
• Identify potential competitor products before they reach market.
• Qualify prospective partners and suppliers.

Contents

• 1
  • 1.1 1.2 2 Introduction
  • 2.1 What is this report about?
  • 2.2 Definitions
    • 2.2.1 Cardiovascular Devices
• 3 Company Snapshot
  • 3.1 Key Information
  • 3.2 Company Overview
  • 3.3 Financial Performance
  • 3.4 Industry Outlook - Cardiovascular Devices
  • 3.5 SWOT Snapshot
• 4 Business Description
  • 4.1 Business Overview
  • 4.2 Cardiovascular
    • 4.2.1 Overview
    • 4.2.2 Financials
    • 4.2.3 Capital Expenditure
    • 4.2.4 Market View
    • 4.2.5 Key Strategies
  • 4.3 ITC
    • 4.3.1 Overview
    • 4.3.2 Financials
    • 4.3.3 Capital Expenditure
    • 4.3.4 Market View
    • 4.3.5 Key Strategies
  • 4.4 Major Products and Services
    • 4.4.1 Overview
• 5 History
• 6 Business Strategy
  • 6.1 Mission Statement
  • 6.2 Strategy
• 7 Value Chain Analysis
  • 7.1 Manufacturing
    • 7.1.1 In House Manufacturing
    • 7.1.2 Outsourcing
  • 7.2 Product Development
    • 7.2.1 Regulatory Approvals
    • 7.2.2 Clinical Trials
    • 7.2.3 Research and Development
  • 7.3 Sales and Marketing
    • 7.3.1 Partnerships and Alliances
    • 7.3.2 Licensing Agreements
• 8 SWOT Analysis
  • 8.1 Overview
  • 8.2 Thoratec Corporation Strengths
    • 8.2.1 Strong R&D
    • 8.2.2 Broad product portfolio of cardiovascular devices
    • 8.2.3 HeartMate II program
  • 8.3 Thoratec Corporation Weaknesses
    • 8.3.1 Decline in revenues
    • 8.3.2 Low returns and margins
    • 8.3.3 Lack of geographic diversification
  • 8.4 Thoratec Corporation Opportunities
    • 8.4.1 Distribution agreement
    • 8.4.2 Acquisition
    • 8.4.3 Expanding HF market
  • 8.5 Thoratec Corporation Threats
    • 8.5.1 Dependent on specialized suppliers
    • 8.5.2 Competition
    • 8.5.3 Heart transplants
• 9 Competitors
• 10 Thoratec Corporation, Medical Equipment Market Share Analysis
  • 10.1 Thoratec Corporation, Global, Market Share (2006)
  • 10.2 Thoratec Corporation, Europe, Market Share (2006)
  • 10.3 Thoratec Corporation, North America, Market Share (2006)
• 11 Revenue Analysis
  • 11.1 Revenue by Segment
  • 11.2 Revenue by Geography
• 12 Financial and Operational Review
  • 12.1 Financial Statements
  • 12.2 Financial Ratios
• 13 Share Holding Structure
• 14 Key Employees
• 15 Key Employee Biographies
• 16 Company Statement
• 17 Locations And Subsidiaries
  • 17.1 Head Office
  • 17.2 Other Locations & Subsidiaries
• 18 Financial Deals Landscape
  • 18.1 Acorn Cardiovascular Secures $22 Million In Financing
  • 18.2 Thoratec And Levitronix Sign A Co-Distribution Agreement
  • 18.3 Thoratec Corporation Completes Private Placement
• 19 Recent Developments
  • 19.1 Nov 19, 2007: Thoratec Appoints New Board Member
  • 19.2 Nov 01, 2007: Thoratec Reports Q3 2007 Results
  • 19.3 Jul 31, 2007: Thoratec Reports Q2 2007 Results
  • 19.4 Jun 21, 2007: Thoratec Appoints New Board Member And Chairman
  • 19.5 May 03, 2007: Thoratec Reports Q1 2007 Results
  • 19.6 Feb 15, 2007: Thoratec Reports Fiscal 2006 Results
  • 19.7 Dec 04, 2006: Thoratec Appoints New CFO
  • 19.8 Oct 31, 2006: Thoratec Reports Q3 2006 Results
  • 19.9 Jul 31, 2006: Thoratec Reports Q2 2006 Results
• 20 Thoratec Corporation Pipeline Products
  • 20.1 HeartMate II LVAS
    • 20.1.1 Product Overview
    • 20.1.2 Product Description
    • 20.1.3 Product Status
    • 20.1.4 Clinical Trials
    • 20.1.5 Product Milestone
  • 20.2 HeartMate III LVAS
    • 20.2.1 Product Overview
    • 20.2.2 Product Description
    • 20.2.3 Product Status
    • 20.2.4 Product Milestone
    • 20.2.5 Product Patent Details
  • 20.3 Heartmate II (BTT)
    • 20.3.1 Product Overview
    • 20.3.2 Product Description
    • 20.3.3 Product Status
    • 20.3.4 Clinical Trials
    • 20.3.5 Product Milestone
  • 20.4 Heartmate II (Clenbuterol)
    • 20.4.1 Product Overview
    • 20.4.2 Product Description
    • 20.4.3 Product Status
  • 20.5 Heartmate II (DT)
    • 20.5.1 Product Overview
    • 20.5.2 Product Description
    • 20.5.3 Product Status
    • 20.5.4 Clinical Trials
    • 20.5.5 Product Milestone
  • 20.6 Heartmate XVE
    • 20.6.1 Product Overview
    • 20.6.2 Product Description
    • 20.6.3 Product Status
  • 20.7 Heartmate XVE (Shock)
    • 20.7.1 Product Overview
    • 20.7.2 Product Description
    • 20.7.3 Product Status
    • 20.7.4 Clinical Trials
• 21 21.1 Global Markets Direct Research Methodology
  • 21.2 Coverage
  • 21.3 Secondary Research
  • 21.4 Primary Research
  • 21.5 Models
  • 21.6 Forecasts
  • 21.7 Expert Panels
  • 21.8 Market Revenue Chapters
    • 21.8.1 Abbreviations
    • 21.8.2 Currency Conversions
  • 21.9 About Global Markets Direct
  • 21.10 Contact Us
  • 21.11 Disclaimer